Results 261 to 270 of about 855,776 (315)
Some of the next articles are maybe not open access.

Management of resistant prolactinomas

Nature Clinical Practice Endocrinology & Metabolism, 2006
Resistance to dopamine agonists occurs in a subset of patients with prolactin-secreting pituitary tumors. The resistance is mediated by loss of pituitary D2 receptors and occurs in both microadenomas and macroadenomas. Cabergoline is the most effective dopamine agonist and tumors that do not respond to bromocriptine or quinagolide frequently respond to
Agusta, Olafsdottir, Janet, Schlechte
openaire   +2 more sources

Management of Resistant Trichomoniasis

Current Infectious Disease Reports, 2019
Trichomonas vaginalis is the most prevalent sexually transmitted parasite in the USA; resistant infection is emerging. New drug therapies and dosing regimens of standard therapies are being studied to treat resistant infection.Diagnosis of trichomoniasis has become more sensitive, specific, and widely available with the advent of nucleic acid ...
Cynthia, Alessio, Paul, Nyirjesy
openaire   +2 more sources

Bt resistance management

Nature Biotechnology, 1998
A plan for reconciling the needs of the many stakeholders in Bacillus thuringiensis endotoxin-based products (including transgenic plants) is considered under the following headings: the problem of resistance, general strategies, a national forum, a need for more research, funding, coordination and education, implementation of resistance management ...
W H, McGaughey, F, Gould, W, Gelernter
openaire   +2 more sources

Management of Multidrug-Resistant Tuberculosis

Seminars in Respiratory and Critical Care Medicine, 2013
AbstractDrug-resistant strains of Mycobacterium tuberculosis pose a major threat to global tuberculosis control. Despite the availability of curative antituberculosis therapy for nearly half a century, inappropriate and inadequate treatment of tuberculosis, as well as unchecked transmission of M.
Charles L, Daley, Jose A, Caminero
openaire   +3 more sources

The management of multidrug-resistant Enterobacteriaceae

Current Opinion in Infectious Diseases, 2016
Purpose of review Multidrug-resistant (MDR) Enterobacteriaceae are often related to the production of extended-spectrum b-lactamases (ESBLs) and carbapenemase-producing Enterobacteriaceae (CRE), and represent an increasing global threat ...
Bassetti M., Peghin M., Pecori D.
openaire   +5 more sources

Nonpharmacological Management of Resistant Hypertension

Current Cardiology Reports, 2021
In the United States (US), 46% of adults have hypertension (systolic blood pressure ≥ 130 mmHg, diastolic blood pressure ≥ 80 mmHg). Approximately, 16% of patients with hypertension have apparent treatment-resistant hypertension (aTRH) and the incidence of true resistant hypertension (RHT) is thought to be much lower (~ 2%). These patients with RHT are
Ahmad Sabbahi   +5 more
openaire   +2 more sources

The management of pesticide resistance

Journal of Theoretical Biology, 1977
Abstract Although the costs of pesticide resistance are hard to quantify, they are an important consideration in choosing control strategies for many pest situations. This paper derives a method for choosing optimal pesticide strategies which takes these costs into account. It is found in the case of a multivoltine pest (given certain general genetic
openaire   +2 more sources

Managing parasiticide resistance

Veterinary Parasitology, 2001
Resistance to antiparasitic drugs is all too common in parasites of veterinary interest. The fact that resistance has arisen in so many different species of parasite and hosts against so many different drugs and in so many geographic areas suggests that the resistances may have common features.
openaire   +2 more sources

Managing ‘resistance’

Current Opinion in Nephrology and Hypertension, 2014
Adherence to preventive measures and prescribed medications is the cornerstone of the successful management of hypertension. The role of adherence is particularly important when treatments are not providing the expected clinical results, for example, in patients with resistant hypertension.
openaire   +3 more sources

Management of insulin allergy and resistance

American Journal of Health-System Pharmacy, 1976
The pathophysiologic basis and therapy of insulin insensitivity and insulin allergy are discussed. Topics covered include primary and secondary causes of insulin insensitivity, management of insulin resistance (elimination of diabetogenic factors; use of less antigenic insulin, oral hypoglycemic agents, immunosuppression, or nonmammalian insulin), and ...
R M, Elenbaas, P J, Forni
openaire   +2 more sources

Home - About - Disclaimer - Privacy